187 related articles for article (PubMed ID: 24702143)
1. Telaprevir in treatment of recurrent hepatitis C infection in liver transplant recipients.
Nair S; Waters B
Exp Clin Transplant; 2014 Apr; 12(2):117-22. PubMed ID: 24702143
[TBL] [Abstract][Full Text] [Related]
2. Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant.
Kwo PY; Ghabril M; Lacerda MA; Joseph Tector A; Fridell JA; Vianna R
Clin Transplant; 2014 Jun; 28(6):722-7. PubMed ID: 24708229
[TBL] [Abstract][Full Text] [Related]
3. Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.
Werner CR; Egetemeyr DP; Lauer UM; Nadalin S; Königsrainer A; Malek NP; Berg CP
Liver Transpl; 2012 Dec; 18(12):1464-70. PubMed ID: 22941516
[TBL] [Abstract][Full Text] [Related]
4. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Antonini TM; Furlan V; Teicher E; Haim-Boukobza S; Sebagh M; Coilly A; Bonhomme-Faivre L; Roque-Afonso AM; Vittecoq D; Samuel D; Taburet AM; Duclos-Vallée JC
AIDS; 2015 Jan; 29(1):53-8. PubMed ID: 25387314
[TBL] [Abstract][Full Text] [Related]
5. Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study.
Rubin RA; Russo MW; Brown KA; Fontana RJ; Levitsky J; Vargas H; Yoshida EM; Brown RS
Exp Clin Transplant; 2018 Apr; 16(2):182-190. PubMed ID: 27855589
[TBL] [Abstract][Full Text] [Related]
6. Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant.
Papadopoulos-Köhn A; Achterfeld A; Paul A; Canbay A; Timm J; Jochum C; Gerken G; Herzer K
Transplantation; 2015 Apr; 99(4):841-7. PubMed ID: 25208324
[TBL] [Abstract][Full Text] [Related]
7. Aggressive use of ribavirin and prolonged course of peginterferon to improve the rate of viral response in liver transplant patients with recurrent hepatitis C viral infection.
Singhal A; Jain AB; Burke M; Black M
Exp Clin Transplant; 2010 Sep; 8(3):214-9. PubMed ID: 20716039
[TBL] [Abstract][Full Text] [Related]
8. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation.
Farnik H; Zimmermann T; Herrmann E; Bechstein WO; Kronenberger B; Galle PR; Labocha S; Ferreiros N; Geisslinger G; Zeuzem S; Sarrazin C; Welker MW
Liver Int; 2015 Jan; 35(1):176-83. PubMed ID: 24649882
[TBL] [Abstract][Full Text] [Related]
9. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
Hézode C; Forestier N; Dusheiko G; Ferenci P; Pol S; Goeser T; Bronowicki JP; Bourlière M; Gharakhanian S; Bengtsson L; McNair L; George S; Kieffer T; Kwong A; Kauffman RS; Alam J; Pawlotsky JM; Zeuzem S;
N Engl J Med; 2009 Apr; 360(18):1839-50. PubMed ID: 19403903
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C.
Forns X; Didier S; Mutimer D; Fagiuoli S; Navasa M; Agarwal K; Berenguer M; Colombo M; Herzer K; Nevens F; Daems B; Janssen K; Ouwerkerk-Mahadevan S; Kimko H; Lathouwers E; Witek J; Van Solingen-Ristea R
Ann Hepatol; 2016; 15(4):512-23. PubMed ID: 27236150
[TBL] [Abstract][Full Text] [Related]
11. Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients.
O'Leary JG; McKenna GJ; Klintmalm GB; Davis GL
Liver Transpl; 2013 Apr; 19(4):463-5. PubMed ID: 23408534
[No Abstract] [Full Text] [Related]
12. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.
McHutchison JG; Everson GT; Gordon SC; Jacobson IM; Sulkowski M; Kauffman R; McNair L; Alam J; Muir AJ;
N Engl J Med; 2009 Apr; 360(18):1827-38. PubMed ID: 19403902
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
Nair S; Lipscomb J; Eason J
Transplantation; 2008 Aug; 86(3):418-22. PubMed ID: 18698245
[TBL] [Abstract][Full Text] [Related]
14. Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.
Satapathy SK; Fiel MI; Vanatta JM; Del Rio Martin J; Schiano TD
Exp Clin Transplant; 2013 Dec; 11(6):522-9. PubMed ID: 23901801
[TBL] [Abstract][Full Text] [Related]
15. Telaprevir for retreatment of HCV infection.
Zeuzem S; Andreone P; Pol S; Lawitz E; Diago M; Roberts S; Focaccia R; Younossi Z; Foster GR; Horban A; Ferenci P; Nevens F; Müllhaupt B; Pockros P; Terg R; Shouval D; van Hoek B; Weiland O; Van Heeswijk R; De Meyer S; Luo D; Boogaerts G; Polo R; Picchio G; Beumont M;
N Engl J Med; 2011 Jun; 364(25):2417-28. PubMed ID: 21696308
[TBL] [Abstract][Full Text] [Related]
16. Response-guided telaprevir combination treatment for hepatitis C virus infection.
Sherman KE; Flamm SL; Afdhal NH; Nelson DR; Sulkowski MS; Everson GT; Fried MW; Adler M; Reesink HW; Martin M; Sankoh AJ; Adda N; Kauffman RS; George S; Wright CI; Poordad F;
N Engl J Med; 2011 Sep; 365(11):1014-24. PubMed ID: 21916639
[TBL] [Abstract][Full Text] [Related]
17. Sofosbuvir and Simeprevir for Treatment of Recurrent Hepatitis C Infection After Liver Transplant.
Nair S; Satapathy SK; Gonzalez HC
Exp Clin Transplant; 2017 Jun; 15(3):314-319. PubMed ID: 26926117
[TBL] [Abstract][Full Text] [Related]
18. Telaprevir for previously treated chronic HCV infection.
McHutchison JG; Manns MP; Muir AJ; Terrault NA; Jacobson IM; Afdhal NH; Heathcote EJ; Zeuzem S; Reesink HW; Garg J; Bsharat M; George S; Kauffman RS; Adda N; Di Bisceglie AM;
N Engl J Med; 2010 Apr; 362(14):1292-303. PubMed ID: 20375406
[TBL] [Abstract][Full Text] [Related]
19. Telaprevir for previously untreated chronic hepatitis C virus infection.
Jacobson IM; McHutchison JG; Dusheiko G; Di Bisceglie AM; Reddy KR; Bzowej NH; Marcellin P; Muir AJ; Ferenci P; Flisiak R; George J; Rizzetto M; Shouval D; Sola R; Terg RA; Yoshida EM; Adda N; Bengtsson L; Sankoh AJ; Kieffer TL; George S; Kauffman RS; Zeuzem S;
N Engl J Med; 2011 Jun; 364(25):2405-16. PubMed ID: 21696307
[TBL] [Abstract][Full Text] [Related]
20. Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.
Buti M; Agarwal K; Horsmans Y; Sievert W; Janczewska E; Zeuzem S; Nyberg L; Brown RS; Hézode C; Rizzetto M; Paraná R; De Meyer S; De Masi R; Luo D; Bertelsen K; Witek J
Gastroenterology; 2014 Mar; 146(3):744-753.e3. PubMed ID: 24316262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]